Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa

Clinical Endocrinology

Volumn 46, Issue 5, 1997, Pages 539-543

  Popovic, V ^a   Micic, D ^a   Djurovic, M ^a   Obradovic, S ^a   Casanueva, F F ^b   Dieguez, C ^b,c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RELEASING FACTOR; HEXARELIN; SERMORELIN;

ADULT; AMENORRHEA; ANOREXIA NERVOSA; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUROENDOCRINOLOGY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0030853015     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.1650982.x     Document Type: Article

References (32)

1. Anon. (1992) NIH Technology Assessment Conference Panel 1992. Methods for voluntary weight loss and control. Annals of Internal Medicine, 116, 942-949.
2. Bowers, C.Y., Sartor, A.O., Reynolds, G.A. & Badger, T.M. (1991) On the actions of the growth hormone-releasing hexapeptide, GHRP-6. Endocrinology, 128, 2027-2035.
3. Brown, G.M., Garfinkel, P.E., Jeuniewic, N., Moldofski, H. & Stancer, H.C. (1977) Endocrine profiles in anorexia nervosa. In Anorexia Nervosa (ed. R. Vigerski) pp. 123-131, New York.
4. Casanueva, F.F., Borras, C.G., Burguera, B., Muruais, C., Fernandez, M. & Devesa, J. (1987) Steroids and neuroendocrine function in anorexia nervosa. Journal of Steroid Biochemistry, 27, 635-640.
5. Clemmons, D.R., Klibanski, A. & Underwood, L.E. (1981) Reduction of plasma immunoreactive somatomedin C during fasting in humans. Journal of Clinical Endocrinology and Metabolism, 53, 1247-1250.
6. Cordido, F., Peñalva, A., Dieguez, C. & Casanueva, F.F. (1993) Massive growth hormone discharge after combined administration of GHRH and GHRP-6: Evidence for a marked somatotroph secretory capability in obesity. Journal of Clinical Endocrinology and Metabolism, 76, 819-823.
7. Crisp, A.R. (1965) Some aspects of evolution, presentation and follow-up of anorexia nervosa. Proceedings of the Royal Society of Medicine, 58, 814-820.
8. De Marinis, L., Folli, G., D'Amico, C., Mancini, A., Sambo, P., Tofani, A., Oradei, A. & Barbarino, A. (1988) Differential effects of feeding on the ultradin variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa. Journal of Clinical Endocrinology and Metabolism, 66, 598-604.
9. Dieguez, C. & Casanueva, F.F. (1995) Influence of metabolic substrates and obesity on growth hormone secretion. Trends in Endocrinology and Metabolism, 6, 55-59.
10. Dinan, T.G., Yatham, L., Barry, S. & O'Keane, V. (1991) Blunting of noradrenergic stimulated growth hormone release in mania. American Journal of Psychiatry, 21, 813-829.
11. Dinan, T.G., O'Keane, V. & Thakore, J. (1994) Pyridostigmine induced growth hormone release in mania: focus on the cholinergic/ somatostatin system. Clinical Endocrinology, 40, 93-96.
12. Ferron, F., Considine, R.V., Peino, R., Lado, I.G., Dieguez, C. & Casanueva, F.F. (1997) Serum heptin concentrations in patients with anorexia nervosa, bulimia nervosa and non specific eating disorders correlate with the body mass index but are independent of the respective disease. Clinical Endocrinology, 46, 289-293.
13. Frankel, R.J. & Jenkins, J.S. (1975) Hypothalamic-pituitary function in anorexia nervosa. Acta Endocrinologica, 78, 209-221.
14. Ghigo, E., Arvat, E., Gianotti, L., Imbimbo, B.P., Lenaerts, V., Deghenghi, R. & Camanni, F. (1994) Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. Journal of Clinical Endocrinology and Metabolism, 78, 693-697.
15. Gold, M.S., Pottash, A.L.C., Sweeney, D.R., Martin, D.M. & Davies, R.K. (1980) Further evidence of hypothalamic-pituitary dysfunction in anorexia nervosa. American Journal of Psychiatry, 137, 101-102.
16. Herzog, D.B. & Copeland, P.M. (1985) Eating disorders. New England Journal of Medicine, 313, 295-303.
17. Isner, J.M., Roberts, W.C., Heymsfield, S.B. & Yager, J. (1985) Anorexia nervosa and sudden death. Annals of Internal Medicine, 102, 49-52.
18. Kelijman, M. & Frohman, L.A. (1988) Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. Journal of Clinical Endocrinology and Metabolism, 66, 489-494.
19. Korbonits, M. & Grossman, A.B. (1995) Growth hormone-releasing peptide and its analogues: novel stimuli to growth hormone release. Trends in Endocrinology and Metabolism, 6, 43-49.
20. Korbonits, M., Trainer, J.P. & Besser, G.M. (1995) The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clinical Endocrinology, 43, 365-371.
21. Micic, D., Popovic, V., Kendereski, A., Peino, R., Dieguez, C. & Casanueva, F.F. (1996) The sequential administration of growth hormone (GH)-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man. Clinical Endocrinology, 45, 543-551.
22. O'Keane, V., O'Flynn, L., Lucey, J. & Dinan, T.G. (1992). Pyridostigmine induced growth hormone responses in healthy and depressed subjects: evidence for cholinergic supersensitivity in depression. Psychological Medicine, 22, 55-60.
23. Ross, R.J.M., Tsagarakis, S., Grossman, A., Nhagafoong, L., Touzel, R.J., Rees, L.M. & Besser, G.M. (1987) GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridosigmine and GHRH. Clinical Endocrinology, 21, 727-732.
24. Russell, G.F.M. (1965) Metabolic aspects of anorexia nervosa. Proceedings of the Royal Society of Medicine, 58, 811-814.
25. Steinhausen, H-C. & Seidel, R. (1993) Outcome in adolescent eating diorders. International Journal of Eating Disorders, 14, 487-496.
26. Stephens, T.W., Basinski, M., Bristow, P.K. et al. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature, 377, 530-532.
27. Study Group on Anorexia Nervosa (1995) Anorexia nervosa: Directions for future research. International Journal of Eating Disorders, 17, 235-241.
28. Thakore, J.H. & Dinan, T.G. (1994) Subnormal growth hormone responses to acutely administered dexamethasone in depression. Clinical Endocrinology , 40, 623-627.
29. Vigersky, R.M. & Loriaux, D.L. (1977) Anorexia nervosa as a model of hypothalamic dysfunction. In Anorexia Nervosa (ed. R. Vigerski), pp. 123-134. Raven Press, New York.
30. Vigersky, R.M., Andersen, A.E., Thompson, R.H. & Loriaux, D.L. (1977) Hypothalamic dysfunction in secondary amenorrhea associated with simple weight loss. New England Journal of Medicine, 297, 1141-1145.
31. Warren, M.P. & Van der Wiele, R.L. (1973) Clinical and metabolic features of anorexia nervosa. American Journal of Obstetrics and Gynaecology, 117, 435-449.
32. Wilson, G.T. & Walsh, B.T. (1991) Eating disorders in the DSM-IV. Journal of Abnormal Psychology, 100, 362-365.